Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2004	FY 2003	FY 2002
Period Ending	Jul '25 Jul 31, 2025	Dec '23 Dec 31, 2023	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Market Capitalization	3	1	38	-	-
Market Cap Growth	-96.98%	-96.98%	-	-	-
Enterprise Value	3	2	38	-	-
Last Close Price	0.03	0.01	1.55	-	-
PS Ratio	-	-	192.05	-	-
PB Ratio	-3398.57	-1523.60	31.28	-	-
EV/Sales Ratio	-	-	190.82	-	-
Debt / Equity Ratio	-1.67	-1.67	0.45	-0.06	-
Asset Turnover	-	-	0.12	-	-
Quick Ratio	0.40	0.40	0.22	0.34	-
Current Ratio	0.40	0.40	0.27	0.37	-
Return on Equity (ROE)	-	-	-1649.23%	-	-
Return on Assets (ROA)	-	-	-235.02%	-	-
Return on Capital (ROIC)	-	-	-472.50%	-	-
Earnings Yield	-0.03%	-0.07%	-22.72%	-	-
FCF Yield	-	-0.07%	-10.52%	-	-
Buyback Yield / Dilution	-269.20%	-269.20%	-63.30%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.